We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Thousands of ED Visits Tied to Dietary Supplements

By HospiMedica International staff writers
Posted on 26 Oct 2015
Dietary supplements are involved in some 23,000 visits to emergency departments (ED) every year in the United States alone, according to a new report.

Researchers at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) used nationally representative surveillance data from 63 EDs between 2004 and 2013 to search for adverse events potentially related to dietary supplements. More...
They found a total of 3,667 such cases reported, from which they estimated that 23,005 ED visits per year could be attributed to adverse events related to dietary supplements. According to the researchers, these visits result in an estimated 2,154 hospitalizations annually.

They found that such visits frequently involve young adults 20–34 years of age and unsupervised children. After exclusion of unsupervised ingestion of dietary supplements by children, 65.9% of ED visits for single-supplement-related adverse events involved herbal or complementary nutritional products, with weight loss and increased energy products commonly implicated; a further 31.8% of cases involved micronutrients. Adverse events included palpitations, chest pain, tachycardia, globus, choking, and pill-induced dysphagia. Micronutrients were implicated in 83.1% of these visits. The study was published on October 15, 2015, in the New England Journal of Medicine (NEJM).

“Although that's less than 5% of the figure for pharmaceutical drugs, dietary supplements are regulated and marketed under the presumption of safety. Cardiac symptoms from weight loss and energy supplements accounted for more ED visits than prescription stimulants,” concluded lead author Andrew Geller, MD, and colleagues. “The study probably underestimated the number of ED visits linked to supplements because their use is underreported by patients, and physicians may not always identify the adverse effects associated.”

The US Dietary Supplement and Health Education Act (DSHEA) stipulates that dietary supplements do not need US Food and Drug Administration (FDA) approval to be marketed, with companies only required to report serious adverse events to the agency. Since the DSHEA was passed in 1994, the estimated number of supplement products rose from 4,000 to more than 55,000 in 2012, amounting to some USD 15 billion spent each year on herbal or complementary nutritional products.

Related Links:

CDC [US] Centers for Disease Control and Prevention



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.